Literature DB >> 17611093

The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.

Alfredo Maqueda1, José V Moyano, Mercedes Hernández Del Cerro, Donna M Peters, Angeles Garcia-Pardo.   

Abstract

Fibronectin matrix assembly involves interactions among various regions of the molecule, which contribute to elongation and stabilization of the fibrils. In this study, we examined the possible role of the heparin III domain of fibronectin (repeats III4-5) in fibronectin fibrillogenesis. We show that a recombinant fragment comprising these repeats (FNIII4-5 fragment) blocked fibronectin fibril formation and the incorporation of 125I-fibronectin into cell layers. Binding assays using a biosensor revealed that FNIII4-5 bound fibronectin and the amino-terminal 70 kDa and 29 kDa fragments. It also bound to itself, indicating a previously unidentified self-association site in repeats III4-5. These interactions were specific since FNIII4-5 did not bind to the FNIII7-10 fragment, representing a central region in fibronectin. The fibronectin-binding property of the III4-5 domain, but not its matrix assembly inhibitory function, was apparently cryptic in larger fragments. By mutating the arginine residues in the WTPPRAQITGYRLTVGLTRR proteoglycan-binding sequence (HBP/III5 site) of FNIII4-5 [Moyano, J.V., Carnemolla, B., Albar, J.P., Leprini, A., Gaggero, B., Zardi, L., Garcia-Pardo, A., 1999. Cooperative role for activated alpha4beta1 integrin and chondroitin sulfate proteoglycans in cell adhesion to the heparin III domain of fibronectin. Identification of a novel heparin and cell binding sequence in repeat III5. J. Biol. Chem. 274, 135-142.], we found that the first two arginine residues in HBP/III5 were involved in the fibronectin-binding property of FNIII4-5, while the last two arginine residues in HBP/III5 were required for inhibition of matrix assembly and the binding of 125I-fibronectin to cell layers. Both properties appear to function independently from each other, depending on the conformation of the fibronectin dimer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17611093     DOI: 10.1016/j.matbio.2007.06.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  12 in total

1.  Fibronectin aggregation and assembly: the unfolding of the second fibronectin type III domain.

Authors:  Tomoo Ohashi; Harold P Erickson
Journal:  J Biol Chem       Date:  2011-09-23       Impact factor: 5.157

Review 2.  Fibronectins, their fibrillogenesis, and in vivo functions.

Authors:  Jean E Schwarzbauer; Douglas W DeSimone
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

3.  Heparin-fibronectin interactions in the development of extracellular matrix insolubility.

Authors:  Irene Raitman; Mia L Huang; Selwyn A Williams; Benjamin Friedman; Kamil Godula; Jean E Schwarzbauer
Journal:  Matrix Biol       Date:  2017-12-06       Impact factor: 11.583

Review 4.  Assembly of fibronectin extracellular matrix.

Authors:  Purva Singh; Cara Carraher; Jean E Schwarzbauer
Journal:  Annu Rev Cell Dev Biol       Date:  2010       Impact factor: 13.827

5.  Disruption of fibronectin matrix affects type IV collagen, fibrillin and laminin deposition into extracellular matrix of human trabecular meshwork (HTM) cells.

Authors:  Mark S Filla; Kaylee D Dimeo; Tiegang Tong; Donna M Peters
Journal:  Exp Eye Res       Date:  2017-08-30       Impact factor: 3.467

6.  Cleavage of extracellular matrix in periodontitis: gingipains differentially affect cell adhesion activities of fibronectin and tenascin-C.

Authors:  Sabrina Ruggiero; Raluca Cosgarea; Jan Potempa; Barbara Potempa; Sigrun Eick; Matthias Chiquet
Journal:  Biochim Biophys Acta       Date:  2013-01-09

7.  Mutations in FN1 cause glomerulopathy with fibronectin deposits.

Authors:  Federica Castelletti; Roberta Donadelli; Federica Banterla; Friedhelm Hildebrandt; Peter F Zipfel; Elena Bresin; Edgar Otto; Christine Skerka; Alessandra Renieri; Marta Todeschini; Jessica Caprioli; Rosa Maria Caruso; Rosangela Artuso; Giuseppe Remuzzi; Marina Noris
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

8.  Prednisone-induced sustained remission in a patient with familial fibronectin glomerulopathy (GFND).

Authors:  Bruce I Goldman; Bernard J Panner; Stephen L Welle; Matthew D Gross; Daniel A Gray
Journal:  CEN Case Rep       Date:  2021-04-10

9.  Plasma and cellular fibronectin: distinct and independent functions during tissue repair.

Authors:  Wing S To; Kim S Midwood
Journal:  Fibrogenesis Tissue Repair       Date:  2011-09-16

10.  Molecular architecture of native fibronectin fibrils.

Authors:  Susanna Maria Früh; Ingmar Schoen; Jonas Ries; Viola Vogel
Journal:  Nat Commun       Date:  2015-06-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.